NorthWest Biotherapeutics Inc (NWBO)

[j e d]

I see what you mean but also remember the title “Unique Challenges in Emerging Immunotherapies” is not specific to LL’s talk, it’s a Session category that five talks including LL’s is under. LL’s specific talk is titled “Autologous Tumor Lysate-loaded Dendritic Cell Vaccination for Glioblastoma.” Looking at the 15 different Session titles, a DCVax talk wouldn’t have fit anywhere else better—none of the categories inspire breakthrough.